Metraipolis › archive › dc_6863d96818ec
A phase 2 randomized controlled trial using biologics to improve multi OIT outcomes (COMBINE): design, rationale, and methods — Europe PMC PMID:41488220
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41488220
- DOI
- 10.3389/falgy.2025.1729111
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T13:25:30.500Z
- SHA-256 of the archived text
beeb3825cfdab5d9cc7b43a3b4269f2b7b84ff16506a10d37db3f97bdf2618d3- Stable URL of this page
https://metraipolis.com/documento/dc_6863d96818ec
How to cite
A phase 2 randomized controlled trial using biologics to improve multi OIT outcomes (COMBINE): design, rationale, and methods — Europe PMC PMID:41488220 — Europe PMC (en), https://europepmc.org/article/MED/41488220 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6863d96818ec (Metraipolis archive dc_6863d96818ec, sha256 beeb3825cfdab5d9cc7b43a3b4269f2b7b84ff16506a10d37db3f97bdf2618d3)
BibTeX
@misc{dc6863d96818ec,
title = {A phase 2 randomized controlled trial using biologics to improve multi OIT outcomes (COMBINE): design, rationale, and methods — Europe PMC PMID:41488220},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41488220},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6863d96818ec; sha256 beeb3825cfdab5d9cc7b43a3b4269f2b7b84ff16506a10d37db3f97bdf2618d3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488220. Agents can read the archived copy with the MCP tool read_document.